Latest Prasugrel Stories
SAN DIEGO, Nov.
INDIANAPOLIS and TOKYO, Sept.
PARSIPPANY, N.J. and INDIANAPOLIS, Sept.
SAN DIEGO, Sept.
CAMBRIDGE, Mass., Aug.
PARIS, July 27 /PRNewswire-FirstCall/ -- Medco Research Institute(TM), LLC, a wholly owned subsidiary of Medco Health Solutions, Inc.
WALTHAM, Mass., July 19 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of acute coronary syndrome (ACS), 56 percent of surveyed interventional cardiologists who prescribe Bristol-Myers Squibb/Sanofi-Aventis' Plavix in high doses, consider it to be comparable in efficacy to Daiichi Sankyo/Eli Lilly's recently-launched Effient.
INDIANAPOLIS and PARSIPPANY, N.J., June 28 /PRNewswire-FirstCall/ -- Daiichi Sankyo, Inc.
SAN DIEGO, May 18 /PRNewswire/ -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed a new agreement with Medico's Hirata for distribution of its VerifyNow System in Japan.
SAN DIEGO, April 6 /PRNewswire/ -- Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow(Â®) System, the first rapid and easy to use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, announced that it has completed the enrollment phase of its landmark clinical trial, GRAVITAS (Gauging Responsiveness with A VerifyNow(Â®) Assay Impact on Thrombosis And Safety).
- A political dynamiter.